W H AT W E D O : W E A R E A F O R M UL ATO R 6 CUSTOM FORMULATION J U LY 2 7 , 2 0 2 3 W E B C A S T P R E S E N TA T I O N COMPOSI TES PORTF OL IO D Y N E E M A ® E X P A N D S O U R E N G I N E E R E D F I B E R S A N D P A N E L S T E C H N O L O G Y LFT Tapes Laminates/Panels Shapes Pultrusion Engineered Fibers 8 DEFENSE TELECOMMUNICATIONS ENERGY TRANSPORTATION Military • Law Enforcement First Responders Body Armor • Helmets Vehicle Protection Sustainable Infrastructure Offshore Wind Electrical Grid Protection EV Battery Components Commercial Laminates Body & Trim • Air Cargo and Railroad Car Panels 5G Applications Fiber Optic Cables Satellite Communications Connectors and Components 9 COMPOSI TES SERVE D IV ER SIF IED END MAR KETS INDUSTRIAL Lifting Slings • Aquaculture High Pressure Pipe Conveyer Springs Q 2 P E R F O R M A N C E Q2 2023 PERFORMANCE VS. Avient reflects 2023 adjusted EBITDA guidance of $525M and estimated run-rate CAPEX of $110M. 2023E (%) 27 79 89 83 83 78 75 90 81 76 72 68 63 53 11 A vi e n t K W R F U L P P G A V Y R P M F M C C E E C L A S H H X L H U N E M N S C L Avient Specialty Formulators Other Specialty / Chemical Companies MULTI PL E EX PANSION Source: Peer data per Bloomberg as of August 17, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $525M and closing share price of $37.07. Avient 2011 and 2018 valuations reflect trailing 12 months EBITDA at December 31 of the respective years. 28 EV / 2023E EBITDA Historic Multiple 6.5 8.3 9.5 13.8 12.7 12.6 11.3 8.7 18.6 16.5 10.1 10.0 9.7 9.5 9.4 8.7 A vi e n t (2 0 1 1 ) A vi e n t (2 0 1 8 ) A vi e n t (2 0 2 3 ) R P M P P G A V Y K W R F U L E C L H X L F M C A S H S C L H U N C E E M N Avient Specialty Formulators Other Specialty / Chemical Companies SEGMENT DATA U.S. & Canada 40% EMEA 37% Asia 18% Latin America 5% 2022 PRO FORMA SEGMENT, END MARKET AND GEOGRAPHY GEOGRAPHY REVENUESEGMENT FINANCIALS Consumer 20% Packaging 24% Industrial 15% Building and Construction 10% Telecommunications 4% Energy 4% Defense 6% END MARKET REVENUE $2,355M $402M $1,300M $272M Sales EBITDA Specialty Engineered Materials Color Additives and Inks $592M$3,653M (1) Transportation 9% Healthcare 8% 30 (1) Total company sales and adjusted EBITDA of $3,653M and $592M, respectively, include intercompany sales eliminations and corporate costs 2 0 2 2 R E V E N U E | $ 2 . 4 B I L L I O N US & Canada 34% EMEA 38% Asia 20% Latin America 8% END MARKET REGION 31 Packaging 34% Consumer 21% Healthcare 8% Industrial 15% Transportation 8% Building & Construction 11% Telecommunications 1% Energy 2% COLOR , AD DI TI VES & INKS 2 0 2 2 P R O F O R M A R E V E N U E | $ 1 . 3 B I L L I O N US & Canada 52% EMEA 35% Asia 13% 32 Packaging 5% Consumer 19% Healthcare 8%Industrial 16% Transportation 10% Telecommunications 10% Energy 9% Defense 15% Building & Construction 8% END MARKET REGION SPEC IA LTY ENGI NEER ED MATERI ALS Packaging 32% Consumer 27% Healthcare 8% Industrial 14% Building & Construction 5% Telecommunications 3% Energy 1% Defense 1% Asia (18% of sales) Transportation 9% 2 0 2 2 P R O F O R M A AV I E N T R E G I O N A L S A L E S Packaging 27% Consumer 14% Healthcare 5% Industrial 17% Building & Construction 10% Energy 5% Defense 8% EMEA (37% of sales)Transportation 11% Packaging 13% Consumer 24% Healthcare 12% Industrial 15% Building & Construction 13% Energy 5% Defense 5% US & Canada (40% of sales) Transportation 7% Packaging 56% Consumer 23% Healthcare 4% Industrial 7% Building & Construction 4% Telecommunications 1% LATAM (5% of sales) Transportation 5% Telecommunications 3% Telecommunications 6% 33 B Y E N D M A R K E T Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except for per share data) Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

KEY CHARACTERISTICS • Manufactured under change control principles beyond CAS number (similar level as MEVOPUR concentrates), reducing risk of change • Free from animal-derived substances and phthalates • Suitable for blown film, injection molding, blow molding and extrusion REGULATORY SUPPORT • Raw materials tested to: - ISO 10993-1 - USP chapters , including Class VI, a requirement for ophthalmic and nasal drugs - European Pharmacopeia 3.1.3/3.1.5 (polyolefin) - USP (polyethylene) - ICH Q3D elemental impurities - USP and USP light transmission • Registered Drug Master File (Type III) • Food contact compliance established with FDA/EU* APPLICATION BULLETIN CARRIER MATERIAL PIGMENT CONTENT/TYPE LIGHT FASTNESS THERMAL STABILITY PRODUCT CODE HDPE 50% TiO2 8 300°C PH00075525 LLDPE 60% TiO2 8 300°C PL00075542 LLDPE 70% TiO2 8 300°C PL00075545 PP 50% TiO2 8 300°C PP00075717 Healthcare use limitations apply—see below.

EURO BLUE W/LOW UV/FD AQUA HDPE CEMENT GRAY

IRON OXIDE RED W ASCORBIC AGM GRAY PP V1 AGM GRAY PP V2

29099 BRIGHT WHITE PCS W/UV 3 (BLUER) UV AQUA GELOY HMF RED UV PE 4

USP Class VI and ISO 10993-4/5 compliant NEU™ Custom Capabilities and NEUSoft™ Thermoplastic Polyurethanes are developed for short-term in-vivo applications that offer good elasticity, radiopacity, excellent UV stability and protection against moisture and oxygen while meeting ISO 10993 & USP Class VI standards.

BLACK W/UV UV SEAFOAM GREEN PE UV IMPACT YELLOW PE

UV GREEN POT COLONIAL WHITE NO UV POLAR MENDE WHITE W/ UV

LAF UV BRIGHT WHITE II FRUCTIS TRANSL LT GREEN w/UV UV CAMEO II

UV CINNAMON GLOSS 966858 PVC RED UV BISQUE PP W/ UV/AM